This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2008 Oct;10(5):345-8.

doi: 10.1007/s11906-008-0065-3.

ONTARGET Study of Telmisartan, Ramipril, or Both in High-Risk Patients

C Venkata S Ram

PMID: 18775109
DOI: 10.1007/s11906-008-0065-3

Comment

ONTARGET Study of Telmisartan, Ramipril, or Both in High-Risk Patients

C Venkata S Ram. Curr Hypertens Rep. 2008 Oct.

. 2008 Oct;10(5):345-8.

doi: 10.1007/s11906-008-0065-3.

Author

C Venkata S Ram

PMID: 18775109
DOI: 10.1007/s11906-008-0065-3

No abstract available

PubMed Disclaimer

Comment on

Telmisartan, ramipril, or both in patients at high risk for vascular events.
ONTARGET Investigators; Yusuf S, Teo KK, Pogue J, Dyal L, Copland I, Schumacher H, Dagenais G, Sleight P, Anderson C. ONTARGET Investigators, et al. N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31. N Engl J Med. 2008. PMID: 18378520 Clinical Trial.

References

1. N Engl J Med. 1992 Sep 3;327(10):669-77 - PubMed
1. Circulation. 1999 Sep 7;100(10):1056-64 - PubMed
1. Lancet. 2002 Mar 23;359(9311):995-1003 - PubMed
1. N Engl J Med. 2003 Nov 13;349(20):1893-906 - PubMed
1. N Engl J Med. 2001 Dec 6;345(23):1667-75 - PubMed

Publication types

Actions